1. Home
  2. CPHI vs ORIS Comparison

CPHI vs ORIS Comparison

Compare CPHI & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • ORIS
  • Stock Information
  • Founded
  • CPHI N/A
  • ORIS 2014
  • Country
  • CPHI China
  • ORIS China
  • Employees
  • CPHI N/A
  • ORIS N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • ORIS Farming/Seeds/Milling
  • Sector
  • CPHI Health Care
  • ORIS Consumer Staples
  • Exchange
  • CPHI Nasdaq
  • ORIS Nasdaq
  • Market Cap
  • CPHI 4.7M
  • ORIS 5.3M
  • IPO Year
  • CPHI N/A
  • ORIS 2024
  • Fundamental
  • Price
  • CPHI $1.68
  • ORIS $0.11
  • Analyst Decision
  • CPHI
  • ORIS
  • Analyst Count
  • CPHI 0
  • ORIS 0
  • Target Price
  • CPHI N/A
  • ORIS N/A
  • AVG Volume (30 Days)
  • CPHI 42.8K
  • ORIS 63.9M
  • Earning Date
  • CPHI 08-14-2025
  • ORIS 01-01-0001
  • Dividend Yield
  • CPHI N/A
  • ORIS N/A
  • EPS Growth
  • CPHI N/A
  • ORIS N/A
  • EPS
  • CPHI N/A
  • ORIS 0.17
  • Revenue
  • CPHI $4,396,201.00
  • ORIS $15,014,000.00
  • Revenue This Year
  • CPHI N/A
  • ORIS N/A
  • Revenue Next Year
  • CPHI N/A
  • ORIS N/A
  • P/E Ratio
  • CPHI N/A
  • ORIS $0.68
  • Revenue Growth
  • CPHI N/A
  • ORIS N/A
  • 52 Week Low
  • CPHI $1.20
  • ORIS $0.08
  • 52 Week High
  • CPHI $3.35
  • ORIS $56.01
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 61.74
  • ORIS 33.79
  • Support Level
  • CPHI $1.34
  • ORIS $0.11
  • Resistance Level
  • CPHI $1.48
  • ORIS $0.12
  • Average True Range (ATR)
  • CPHI 0.10
  • ORIS 0.01
  • MACD
  • CPHI 0.03
  • ORIS 0.02
  • Stochastic Oscillator
  • CPHI 98.53
  • ORIS 47.00

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: